GSK offers $1 billion to raise stake in Indian unit

The UK-listed group offers to raise its stake in GlaxoSmithKline Pharmaceuticals, its Indian drug unit, boosting its investment in the country.

GSK offers $1 billion to raise stake in Indian unit

GlaxoSmithKline GSK on Monday became the latest multinational to boost its investments in India, with a 629 million $1 billion offer to increase its stake in its India-listed drug unit

The UK-listed pharmaceuticals group is offering Rp3100 per share in GlaxoSmithKline Pharmaceuticals, a premium of about 26% to the stock's December 13 close on the National Stock Exchange of India, taking its stake from 50.7% to as much as 75%....

FinanceAsia has updated its subscription model. Registered readers now have the opportunity to read five articles from our award-winning website for free. Please subscribe for unlimited access.

Click for more on: gsk | hsbc

Print Edition

FinanceAsia Print Edition